The 2.25 cc prefilled 50 mcg/mL screening dose syringe offers evacuation of cerebrospinal fluid, which yields an increased flow rate in the intrathecal space.
For patients found to be responsive to bolus screening, Gablofen® offers 3 treatment concentrations – 500, 1,000, 2,000 mcg/mL — to help optimize ITB Therapy (Intrathecal Baclofen Therapy).2
Contact us to request a trial program for the opportunity to receive samples and education that will familiarize you and your patients with Gablofen®.